Phase 3 KEYNOTE-A18 Trial Data Are ‘Practice Changing’ for Cervical Cancer
November 22nd 2023Domenica Lorusso, MD, PhD, says that paying attention to the quality of chemoradiotherapy is imperative to feeling confident about the potential addition of pembrolizumab for locally advanced cervical cancer.